文献速递先天性心脏病外科

单心室患儿一期姑息手术的真实世界结局:KID数据库分析

Contemporary Real-world Outcomes of Stage 1 Palliation for Single-ventricle Patients: A Kids' Inpatient Database Analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

该研究利用美国Kids' Inpatient Database(KID)2016与2019年数据,纳入1918例接受一期姑息手术的单心室合并体循环流出道梗阻患儿,比较Norwood-Sano、Norwood-mBTT shunt与hybrid三种术式的结局。结果显示风险校正后三种术式住院死亡与ECMO需求无显著差异,高死亡率医院更多采用mBTTs或hybrid。

要点

  • 风险校正后Norwood-mBTTs与hybrid较Norwood-Sano的住院死亡无显著差异
  • 三种术式风险校正后ECMO需求亦无显著差异
  • 高死亡率医院更倾向采用mBTTs或hybrid术式

核心结论

  • 与历史数据相比,一期姑息手术结局正在改善。
  • 风险校正后Norwood-Sano与Norwood-mBTTs在住院死亡与ECMO需求上无差异。
  • 这些数据可能有助于术式策略的演变。

研究设计与样本

  • 基于Kids' Inpatient Database(KID)2016、2019年数据,使用ICD-10编码提取Norwood与hybrid手术病例。
  • 采用调查权重估算全国队列,共1918例接受一期姑息手术。
  • 使用多水平多变量logistic回归评估风险校正死亡与术后ECMO。

主要发现

  • Norwood-Sano 1046例(54.5%),Norwood-mBTT shunt 770例(40.1%),hybrid 102例(5.3%)。
  • 未校正住院死亡:Norwood-Sano 9.0%,Norwood-mBTT shunt 11.5%,hybrid 18.7%。
  • 风险校正后Norwood-mBTTs的OR 1.25(P=.248),hybrid的OR 2.01(P=.057),均与Norwood-Sano无显著差异。
  • ECMO需求:Norwood-mBTT shunt OR 0.90(P=.78),hybrid OR 0.50(P=.37)。
  • 与Norwood-Sano相比,高死亡率医院中mBTTs或hybrid使用更多。

临床怎么用

  • 可为单心室一期姑息术式选择提供真实世界风险校正参考。
  • 提示术式结局差异可能受医院死亡率水平影响,需结合中心经验判断。

局限性

  • 原文未报告具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients with a single ventricle and systemic outflow obstruction undergo 1 of 3 stage 1 palliative operations: Norwood-Sano, Norwood-Modified Blalock-Taussig-Thomas shunt (mBTTs), or stage 1 hybrid palliation. We evaluated real-world outcomes for patients undergoing stage 1 palliation strategies in a national dataset. METHODS: The Kids' Inpatient Database (KID) was queried for patients undergoing Norwood and hybrid procedures for the years 2016, 2019, and 2019. Data were extracted using International Classification of Diseases (ICD-10) codes. Using survey weights, an estimated national cohort was derived. Multilevel, multivariable logistic regression models evaluated risk-adjusted mortality and post-operative extracorporeal membrane oxygenation (ECMO). Operations were plotted by hospital mortality for the entire sample. RESULTS: A total of 1918 patients underwent stage 1 palliation with Norwood-Sano (1046, 54.5%), Norwood-mBTT shunt (770, 40.1%), or hybrid procedure (102, 5.3%). Unadjusted inpatient mortality was 9.0% for Norwood-Sano, 11.5% for Norwood-mBTT shunt, and 18.7% for the hybrid procedure. After risk adjustment, there was no significant difference in risk-adjusted inpatient mortality for Norwood-mBTTs (OR 1.25, P = .248) or hybrid procedures (OR 2.01, P = .057) compared to Norwood-Sano. There was no difference in need for ECMO for Norwood-mBTT shunt (OR 0.90, P = .78), or hybrid procedure (OR 0.50, P = .37). Finally, compared to Norwood-Sano, the use of mBTTs or hybrid procedures was higher in high-mortality hospitals. CONCLUSIONS: Compared to historical data, outcomes for stage 1 palliative procedures are improving over historical norms. There was no difference in risk-adjusted inpatient mortality or ECMO comparing Norwood-Sano to Norwood-mBTTs. These data may aid the evolution of operative strategies.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Chauhan D, Mehaffey JH, Hayanga JWA, et al. Contemporary Real-world Outcomes of Stage 1 Palliation for Single-ventricle Patients: A Kids' Inpatient Database Analysis. Eur J Cardiothorac Surg. 2025. PMID: 41264467. doi:10.1093/ejcts/ezaf423

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。